Pafolacianine Sodium Patent Expiration
Pafolacianine Sodium is used for aiding in the intraoperative identification of malignant lesions in adult patients with ovarian cancer. It was first introduced by On Target Laboratories Inc
Pafolacianine Sodium Patents
Given below is the list of patents protecting Pafolacianine Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Cytalux | US9254341 | Methods of manufacture of pteroyl-amino acid-fluorescent dyes | Oct 04, 2033 | On Target Labs |
| Cytalux | US10881747 | Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors | Aug 26, 2033 | On Target Labs |
| Cytalux | US9061057 | Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors | Aug 26, 2033 | On Target Labs |
| Cytalux | US9333270 | Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors | Aug 26, 2033 | On Target Labs |
| Cytalux | US9341629 | Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors | Aug 26, 2033 | On Target Labs |
| Cytalux | US9789208 | Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors | Aug 26, 2033 | On Target Labs |
Pafolacianine Sodium's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List